FORSYTH DOUGLAS
Insider CIK 1240801 · NCV · NIE · INBX Director · INBX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 2,500 | $114.65 | $286.6K | 227,064 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 2,500 | $114.65 | $286.6K | 227,064 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-23 | 2024-08-26 | 59,812 | $14.07 | $841.6K | 224,564 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-22 | 2024-08-26 | 15,188 | $12.89 | $195.8K | 164,752 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award deriv | 2024-05-30 | 2024-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 17,259 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 598,257 | $30.00 | $17.95M | 0 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 149,564 | — | $0 | 149,564 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 47,259 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2021-06-07 | 2021-06-08 | 15,000 | — | $0 | 32,259 | SEC↗ |
| INBX Inhibrx, Inc. | C Conversion deriv | 2020-08-21 | 2020-08-21 | 143,266 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | C Conversion | 2020-08-21 | 2020-08-21 | 82,422 | — | $0 | 598,257 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 1,900 | $24.64 | $46.8K | 4,600 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 709 | $24.66 | $17.5K | 6,500 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 600 | $24.64 | $14.8K | 4,000 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 4,000 | $24.63 | $98.5K | 0 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 1,791 | $24.70 | $44.2K | 7,209 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 800 | $24.66 | $19.7K | 9,000 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 100 | $24.67 | $2.5K | 9,800 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 100 | $24.69 | $2.5K | 9,900 | SEC↗ |
| NIE AllianzGI Equity & Convert | S Sale | 2020-08-11 | 2020-08-13 | 10,000 | $24.68 | $246.8K | 10,000 | SEC↗ |
| NCV AllianzGI Convertible & In | S Sale | 2014-06-25 | 2014-06-27 | 2,500 | $10.58 | $26.4K | 0 | SEC↗ |
| NCV AllianzGI Convertible & In | S Sale | 2014-06-25 | 2014-06-27 | 9,000 | $10.58 | $95.2K | 2,500 | SEC↗ |
| NCV AllianzGI Convertible & In | S Sale | 2014-06-25 | 2014-06-27 | 2,500 | $10.57 | $26.4K | 11,500 | SEC↗ |
| NCV AllianzGI Convertible & In | S Sale | 2014-06-25 | 2014-06-27 | 1,000 | $10.57 | $10.6K | 14,000 | SEC↗ |